documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

6 rows where docket_id = "FDA-2006-P-0069" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 3

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-P-0069-0006 FDA ANDA for ELOXATIN (oxaliplatin for injection) lyophilized powder for infusion, 50 mg and 100 mg vials FDA-2006-P-0069 Citizen Petition from Frommer, Lawrence & Haug, LLP Other CP-Citizen Petition 2009-03-17T04:00:00Z 2009 3 2009-03-17T04:00:00Z   2024-11-13T14:57:49Z   0 0 0900006480444455
FDA-2006-P-0069-0005 FDA ANDA for ELOXATIN (oxaliplatin for injection) lyophilized powder for infusion, 50 mg and 100 mg vials FDA-2006-P-0069 Letter from FDA CDER to Frommer, Lawrence & Haug LLP Other Letter(s) 2007-11-30T05:00:00Z 2007 11     2024-11-13T14:54:20Z   0 0 0900006480444465
FDA-2006-P-0069-0004 FDA ANDA for ELOXATIN (oxaliplatin for injection) lyophilized powder for infusion, 50 mg and 100 mg vials FDA-2006-P-0069 Notice of Determination Notice N-Notice 2007-11-27T05:00:00Z 2007 11 2007-11-23T05:00:00Z   2024-11-13T14:49:01Z   0 0 0900006480444464
FDA-2006-P-0069-0003 FDA ANDA for ELOXATIN (oxaliplatin for injection) lyophilized powder for infusion, 50 mg and 100 mg vials FDA-2006-P-0069 Letter from FDA CDER to Frommer, Lawrence & Haug LLP Other Letter(s) 2007-02-08T05:00:00Z 2007 2     2024-11-13T14:48:28Z   0 0 0900006480444463
FDA-2006-P-0069-0002 FDA ANDA for ELOXATIN (oxaliplatin for injection) lyophilized powder for infusion, 50 mg and 100 mg vials FDA-2006-P-0069 Acknowledgment Letter from FDA DMB to Frommer, Lawrence & Haug, LLP Other Acknowledgement Letter/Receipt 2006-08-07T04:00:00Z 2006 8     2024-11-13T14:47:26Z   0 0 090000648044445f
FDA-2006-P-0069-0001 FDA ANDA for ELOXATIN (oxaliplatin for injection) lyophilized powder for infusion, 50 mg and 100 mg vials FDA-2006-P-0069 Acknowledgment Letter from FDA DMB to Frommer, Lawrence & Haug, LLP Other Acknowledgement Letter/Receipt 2006-08-07T04:00:00Z 2006 8     2024-11-13T14:46:19Z   0 0 0900006480444454

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);